Old Web
English
Sign In
Acemap
>
authorDetail
>
Nisha Mohindra
Nisha Mohindra
Medicine
Oncology
Internal medicine
Pathology
Pembrolizumab
5
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment
2019
Journal of Thoracic Oncology
Nicholas I. Simon
Young Kwang Chae
Nisha Mohindra
Victoria M. Villaflor
Show All
Source
Cite
Save
Citations (0)
P1.01-49 Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC
2019
Journal of Thoracic Oncology
Andrew A. Davis
W. Iams
David C. Chan
Michael S. Oh
Robert William Lentz
Neil Peterman
Alex. Robertson
Abhik Shah
Rohith Srivas
Nicole J. Lambert
T Wilson
Ayse Tezcan
John C. Spinosa
Haluk Tezcan
Nisha Mohindra
Victoria M. Villaflor
Young Kwang Chae
Show All
Source
Cite
Save
Citations (0)
P1.03-38 EGFR Mutation Status as a Prognostic Marker in Stage 1 Lung Adenocarcinoma After Definitive Surgical Resection
2019
Journal of Thoracic Oncology
Carlos Galvez
Saya Jacob
Jeffrey Zhao
Kyle Tegtmeyer
Brian S. Finkelman
Young Kwang Chae
Nisha Mohindra
Borko Jovanovic
Amir Behdad
Victoria M. Villaflor
Show All
Source
Cite
Save
Citations (0)
P1.01-67 Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC (HCRN LUN13-175): Outcomes by Nab-Paclitaxel Dose
2019
Journal of Thoracic Oncology
Ryan D. Gentzler
Nisha Mohindra
Shadia I. Jalal
Karen L. Reckamp
R Hall
Nasser H. Hanna
Young Kwang Chae
Victoria M. Villaflor
Marianna Koczywas
Irene B. Helenowski
Alfred W. Rademaker
Jyoti D. Patel
Show All
Source
Cite
Save
Citations (0)
Current state of immunotherapy: chipping away at the tip of the iceberg.
2018
Cancer immunology research
Nisha Mohindra
Show All
Source
Cite
Save
Citations (2)
1